We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $22.8B
1-Year Est. Return 25.09%
This Fund
S&P 500
This Quarter Est. Return
-18.34%
1 Year Est. Return
+25.09%
3 Year Est. Return
+81.82%
5 Year Est. Return
+99.92%
10 Year Est. Return
+339.81%
AUM
$12.3B
AUM Growth
-$3.39B
Cap. Flow
-$230M
Cap. Flow %
-1.88%
Top 10 Hldgs %
40.1%
Holding
1,382
New
275
Increased
214
Reduced
491
Closed
232

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$272M
2
BAX icon
Baxter International
BAX
+$272M
3
MA icon
Mastercard
MA
+$213M
4
ALC icon
Alcon
ALC
+$192M
5
AVTR icon
Avantor
AVTR
+$110M

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Financials 16.13%
3 Consumer Staples 15.16%
4 Industrials 13.67%
5 Technology 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
301
Novo Nordisk
NVO
$203B
$284K ﹤0.01%
9,424
-5,816
-38% -$173K
ICUI icon
302
ICU Medical
ICUI
$4.48B
$283K ﹤0.01%
1,403
-39
-3% -$7.51K
GLW icon
303
Corning
GLW
$144B
$280K ﹤0.01%
13,618
+108
+0.8% +$2.82K
JKHY icon
304
Jack Henry & Associates
JKHY
$10.8B
$279K ﹤0.01%
1,800
-5
-0.3% -$777
XLV icon
305
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$277K ﹤0.01%
3,129
-1,227
-28% -$119K
BNY
306
Bank of New York Mellon
BNY
$111B
$274K ﹤0.01%
8,146
-683
-8% -$28.7K
PSX icon
307
Phillips 66
PSX
$90B
$273K ﹤0.01%
5,087
-7,889
-61% -$642K
AMAT icon
308
Applied Materials
AMAT
$435B
$271K ﹤0.01%
5,916
+1,627
+38% +$93.5K
BSX icon
309
Boston Scientific
BSX
$74.5B
$271K ﹤0.01%
8,307
+49
+0.6% +$1.91K
CHRW icon
310
C.H. Robinson
CHRW
$17.1B
$271K ﹤0.01%
4,087
+257
+7% +$18.5K
TSLA icon
311
Tesla
TSLA
$1.29T
$268K ﹤0.01%
7,665
+75
+1% +$3.11K
KMX icon
312
CarMax
KMX
$8.33B
$266K ﹤0.01%
4,949
-2,371
-32% -$201K
GPC icon
313
Genuine Parts
GPC
$18.5B
$264K ﹤0.01%
3,925
-1,030
-21% -$91.7K
WLY icon
314
John Wiley & Sons Class A
WLY
$2.53B
$262K ﹤0.01%
7,000
+2,250
+47% +$94.4K
PPG icon
315
PPG Industries
PPG
$25.5B
$259K ﹤0.01%
3,096
-403
-12% -$44.8K
LBTYK icon
316
Liberty Global Class C
LBTYK
$3.46B
$254K ﹤0.01%
16,143
-12,038
-43% -$226K
PSQ icon
317
ProShares Short QQQ
PSQ
$642M
$254K ﹤0.01%
2,000
VRSN icon
318
VeriSign
VRSN
$25.6B
$252K ﹤0.01%
1,398
-14
-1% -$2.75K
GSK icon
319
GSK
GSK
$101B
$248K ﹤0.01%
5,238
-3,941
-43% -$210K
ZEN
320
DELISTED
ZENDESK INC
ZEN
$248K ﹤0.01%
3,868
-490
-11% -$38.2K
EXPD icon
321
Expeditors International
EXPD
$24B
$247K ﹤0.01%
3,706
-543
-13% -$38.7K
CTAS icon
322
Cintas
CTAS
$81.4B
$246K ﹤0.01%
5,688
+68
+1% +$4.44K
IEUR icon
323
iShares Core MSCI Europe ETF
IEUR
$9.14B
$246K ﹤0.01%
6,640
-7,026
-51% -$317K
NOC icon
324
Northrop Grumman
NOC
$82B
$244K ﹤0.01%
808
-486
-38% -$169K
KHC icon
325
Kraft Heinz
KHC
$29.1B
$242K ﹤0.01%
9,785
-67
-0.7% -$1.84K

Similar funds

Brown Brothers Harriman & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Brown Brothers Harriman & Co held 1,382 positions worth $12.3B, down 22% from $15.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Brown Brothers Harriman & Co's Q1 2020 filing shows 275 new, 214 increased, 491 reduced and 232 closed positions. Its largest new stake was Avantor: 6,874,553 shares worth $85.9M. The largest sale was US Bancorp, an estimated $505M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Staples.

  • Brown Brothers Harriman & Co's largest Q1 2020 buy was Avantor: 6,874,553 shares worth $85.9M.
  • Brown Brothers Harriman & Co added most to Nike in Q1 2020, an estimated $272M increase.
  • Brown Brothers Harriman & Co's biggest Q1 2020 reduction was US Bancorp, cutting an estimated $505M.
  • Brown Brothers Harriman & Co fully exited RTX Corp in Q1 2020, selling an estimated $16.2M.
  • Brown Brothers Harriman & Co's ten largest holdings make up 40% of its $12.3B portfolio in Q1 2020.
  • Brown Brothers Harriman & Co opened 275 new positions and closed 232 in Q1 2020.
  • Brown Brothers Harriman & Co's portfolio value fell 22% quarter-over-quarter to $12.3B.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2020, filed 15 May 2020.